ANAS ALJANADI

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology GRAND RAPIDS, MI NPI 1790727360

General Payments — all program years on this page

$118,996.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 188
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $10,232.60 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $8,162.503
Food and Beverage $1,524.2515
Travel and Lodging $545.851

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $93,214.98119
2019 $3,046.2814
2020 $540.784
2021 $6,097.538
2022 $1,667.6611
2023 $4,196.6813
2024 $10,232.6019

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078747334 Janssen Biotech, Inc. $127.45 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086753891 Novartis Pharmaceuticals Corporation $2,362.50 08/20/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101389982 E.R. Squibb & Sons, L.L.C. $206.71 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103194608 ABBVIE INC. $28.98 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111514167 Amgen Inc. $44.75 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115959990 GlaxoSmithKline, LLC. $3,625.00 07/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116296807 GlaxoSmithKline, LLC. $2,175.00 07/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1120845940 BeiGene USA, Inc. $78.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121187536 ADC Therapeutics America, Inc. $63.00 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126532950 Geron Corporation $124.45 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131621843 PFIZER INC. $545.85 12/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132975861 Genentech USA, Inc. $135.84 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132975863 Genentech, Inc. $143.23 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008252 GENZYME CORPORATION $143.49 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008256 GENZYME CORPORATION $124.88 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008264 GENZYME CORPORATION $113.27 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008272 GENZYME CORPORATION $6.85 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1140008278 GENZYME CORPORATION $141.66 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147258040 SERVIER PHARMACEUTICALS LLC $41.69 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.